Medication info

Daidian Duo Tablet 12.5/850 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
HanKook HuTex Pharmaceuticals Co., Ltd.
Appearance
White film-coated tablets that are oval-shaped with a pink tint on both sides
Packaging
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]
Approval status
Approval withdrawn

MFDS item code 202302529 · Approved 2023.08.25

This product's status changed to Approval withdrawn on 2026.02.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose when taking this medication is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medication, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Administration with Caution in the Following Patients, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medication must be discontinued immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
HanKook HuTex Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood sugar control
  • cardiovascular disease
View approved original text

This medication is used to assist dietary and exercise regimens for blood sugar control in adult patients with type 2 diabetes. In particular, it effectively improves blood sugar levels by combining empagliflozin and metformin. It can also be applicable for adult type 2 diabetes patients with cardiovascular disease who are not achieving adequate blood sugar control; in this case, it is important to refer to professional guidelines and clinical study information. This treatment helps improve blood sugar management and supports maintaining a healthy lifestyle.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose when taking this medication is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medication, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Administration with Caution in the Following Patients, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medication must be discontinued immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication is intended to help lower blood sugar levels. However, there is a risk of a rare side effect called severe lactic acidosis, which requires caution. Lactic acidosis can lead to serious conditions due to the accumulation of lactic acid in the body and can sometimes be life-threatening. Additionally, caution is necessary as there is a risk of hypoglycemia when taken in conjunction with insulin or other diabetes medications. Patients with poor renal function or those experiencing acute infection, dehydration, or heart problems should not take this medication. Usage is prohibited, especially in cases of acute myocardial infarction, shock, and sepsis. Patients scheduled for surgery should stop taking this medication 48 hours before the surgery and should not resume until renal function is confirmed to be normal afterwards. It is also safe for pregnant or breastfeeding women to avoid using this medication. Regular renal function tests should be conducted during the use of this medication, and extra caution is required if there is fluid loss. Furthermore, this medication can increase the risk of urinary tract infections or genital infections, so immediate consultation with a doctor is needed if symptoms of infection occur. Symptoms such as nausea, vomiting, diarrhea, and abdominal pain may occur during use, and any severe symptoms should be reported to a doctor. This medication can lower vitamin B12 levels, so blood tests should be conducted if taken over a long period. Alcohol consumption may increase the risk of lactic acidosis, hence it is advisable to avoid alcohol while on this medication. The effects on driving or operating machinery are not clearly established, so caution is necessary. In cases of overdose, immediate medical attention is required, particularly if lactic acidosis symptoms are suspected. This medication is not recommended for children, and elderly patients should take it while closely monitoring renal function. During the use of this medication, regular health check-ups and adherence to doctor's instructions are crucial.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased vitamin B12 and deficiency
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • nausea
  • vomiting
Show 126 more
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disturbance
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vulvovaginal disease
  • vulvitis
  • balanitis
  • perineal necrosis
  • hypotension
  • dehydration
  • low blood pressure
  • decreased blood volume
  • orthostatic hypotension
  • fainting
  • headache
  • dizziness
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • chronic gastritis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disturbance
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • position-related dizziness
  • memory disturbance
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • fever
  • facial swelling
  • chills
  • strange sensation
  • edema
  • pain
  • pain at puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • chest pain
  • weight loss
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • double vision
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • cough
  • epistaxis
  • allergic rhinitis
  • skin laceration
  • rib fracture
  • ligament strain syndrome
  • angina pectoris
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disturbance
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • position-related vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disturbance
  • nasopharyngitis
  • herpes zoster
  • dizziness
  • chest discomfort
  • chest pain
  • asthenia
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • lower back pain
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy and safety of the medication.

Appearance and packaging

Appearance

White film-coated tablets that are oval-shaped with a pink tint on both sides

Package unit

60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.